Table 3.
Outcomes | Studies, N | DIEP | fTRAM | Effect Size | 95% CI | I2 | ||
---|---|---|---|---|---|---|---|---|
No. Events | No. Patients | No. Events | No. Patients | |||||
Total or partial flap loss | 8 | 73 | 1083 | 50 | 1401 | 2.67 | 1.00 to 4.34 | 87.62% |
Without obese patients | 7 | 68 | 978 | 45 | 1101 | 2.64 | 0.83 to 4.45 | 88.57% |
Muscle-sparing only | 4 | 65 | 899 | 21 | 632 | 1.93 | 0.26 to 3.61 | 87.57% |
fTRAM | DIEP | |||||||
Outcomes | Studies, N | No. Events | No. Patients | No. Events | No. Patients | Effect Size | 95% CI | I2 |
Mastectomy skin flap necrosis | 4 | 154 | 604 | 58 | 235 | 0.96 | −1.31 to 3.28 | 0 |
Without obese patients | 3 | 28 | 304 | 8 | 130 | 1.03 | −1.71 to 3.77 | 0 |
Fat necrosis (breast) | 7 | 133 | 1430 | 143 | 1065 | 0.80 | −0.83 to 2.44 | 0 |
Without obese patients | 6 | 125 | 1130 | 133 | 960 | 0.89 | −0.88 to 2.66 | 0 |
Muscle-sparing only | 4 | 67 | 684 | 126 | 899 | 0.83 | −1.32 to 2.98 | 0 |
Infection (breast) | 5 | 63 | 1041 | 47 | 905 | 2.60 | 0.54 to 4.65 | 71.51% |
Without obese patients | 4 | 51 | 741 | 44 | 800 | 2.93 | 0.61 to 5.26 | 78.60% |
Muscle-sparing only | 2 | 42 | 560 | 45 | 364 | 2.10 | −1.04 to 5.23 | 70.20% |
Hematoma/seroma (breast) | 5 | 55 | 1041 | 72 | 905 | 0.80 | −1.20 to 2.80 | 15.91% |
Without obese patients | 4 | 48 | 741 | 68 | 800 | 0.85 | −1.40 to 3.10 | 36.80% |
Muscle-sparing only | 2 | 25 | 560 | 41 | 364 | 0.43 | −2.59 to 3.46 | 0 |
Wound healing complications, any (breast) | 3 | 132 | 582 | 52 | 217 | 0.93 | −1.74 to 3.59 | 0 |
Without obese patients | 2 | 6 | 282 | 2 | 112 | 0.96 | −2.49 to 4.40 | 0 |
Abdominal bulge/hernia | 9 | 94 | 1253 | 40 | 1030 | 2.87 | 1.73 to 4.00 | 70.48% |
Without obese patients | 8 | 76 | 953 | 39 | 925 | 2.35 | 1.49 to 3.21 | 41.44% |
Muscle-sparing only | 5 | 56 | 612 | 36 | 855 | 2.55 | 1.42 to 3.67 | 62.83% |